openPR Logo
Press release

Drug Delivery Systems Market expected to grow at a CAGR of 7.2% during the forecast period 2019 To 2027 With : BD, Novo Nordisk, 3M, Boston Scientific, Bausch Health Companies, Baxter International, And Others

05-16-2019 03:04 PM CET | Health & Medicine

Press release from: The Insight Partners

Drug Delivery Systems Market

Drug Delivery Systems Market

The global drug delivery systems market accounted to US$ 1,243.1 Bn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 – 2027, to account to US$ 2,302.2 Bn by 2027.

Asia Pacific is the fastest growing geographic market and it is expected to be the second largest revenue contributor throughout the forecast period. The growth is contributed majorly by driving factors such as significant rise in the prevalence of chronic diseases across the countries, rise in the government support for the patient population. In addition, the market players are also developing novel products in the countries through robust R&D activities and partnerships and acquisitions.

Get Sample Copy Of Report@ https://www.theinsightpartners.com/sample/TIPHE100000854/?OP-sp

The global drug delivery systems market by product segments was led by oral drug delivery segment. In 2018, the oral drug delivery segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The transmucosal segment is expected to be the fastest growing segments the market in 2027 owing to rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders.

Some Of Key Company Profiles

• BD
• Novo Nordisk A/S
• 3M
• Boston Scientific Corporation
• Bausch Health Companies Inc.
• Baxter International, Inc.,
• Boehringer Ingelheim
• Novartis AG
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc

Market Insights :

Rising Incidence of Chronic Diseases

Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to increasing prevalence of chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.

Some important technological advantages of nanotherapeutic drug delivery systems (NDDS) include prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug and many more.

Growing Demand for Non Invasive Drug Delivery Devices

With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectible routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

Speak with Industrial Experts@ https://www.theinsightpartners.com/inquiry/TIPHE100000854/?OP-sp

Global Drug Delivery Systems Market – By Route of Administration

• Oral
• Transmucosal
• Injectable
• Topical
• Implantable
• Ocular

Global Drug Delivery Systems Market – By Application

• Hospital & Clinics
• Home Care Settings
• Others

Global Drug Delivery Systems Market – By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Product Insights

The global drug delivery systems market by product segments was led by oral drug delivery segment. In 2018, the oral drug delivery segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The transmucosal segment is expected to be the fastest growing segments the market in 2027 owing to rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders.

Strategic Insights

Product launches and up gradation were observed as the most adopted strategy in global drug delivery systems industry. For instance, in January 2019, BD launched BD Nano 2nd gen pen needles reinforces BD’s commitment to providing the most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use. The developments performed by the companies are helping the market to grow in the coming years

Get Instant Discount On this Report@ https://www.theinsightpartners.com/discount/TIPHE100000854/?OP-sp

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Systems Market expected to grow at a CAGR of 7.2% during the forecast period 2019 To 2027 With : BD, Novo Nordisk, 3M, Boston Scientific, Bausch Health Companies, Baxter International, And Others here

News-ID: 1742244 • Views: 467

More Releases from The Insight Partners

Oncology Biosimilars Market Key Insights, Booming Growth with Top Key Manufactur …
Worldwide Oncology Biosimilars Market Analysis to 2027 is a specialized and in-depth study of the Oncology Biosimilars industry with a focus on the global market trend. The report aims to provide an overview of global Oncology Biosimilars market with detailed market segmentation by product & services /application and geography. The global Oncology Biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on
Mooring Inspection Market Outlook to 2027 - Leading Players Acteon Group, Deep S …
Mooring anchoring systems are very significant to ensure the safe functionality of offshore loading systems. Thus, the reliability of mooring components is of extreme significance to safeguard breakage-free operations through the entire service life of the facility. Mooring inspection is performed on a routine basis in offshore operations to ensure the integrity of mooring components. The significance of detect defects in a mooring system to ensure safe offshore and onshore operations
Diagnostic Tympanometers Market Report Gives Immense Knowledge on the Competitiv …
Diagnostic tympanometers is an audiometric diagnostic device consisting of tone generator, pressure pump and microphone used to measure the movement of the tympanic membrane and access the function of the middle ear. This market research report provides a comprehensive picture on “Diagnostic Tympanometers Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete
Multi Flue Chimney Caps Market Outlook to 2027 - Artis Metals, Chim Cap, Chimney …
Multi-flue chimney caps are useful in protecting the chimney crown. They are available in stainless steel, concrete, or copper. Multi-flue chimney caps can accommodate single or multiple flues in one chimney structure. A rise in commercial and residential projects is expected to generate substantial demand for multi-flue chimney caps in the forecast period. The multi flue chimney caps market is anticipated to grow in the forecast period owing to various advantages

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning